One such example, found in 50 % of prostate cancers, involves the fusion between the ETS transcription factor ERG with the androgen-regulated gene TMPRSS2, resulting in overexpression of ERG in the prostate epithelium [1]. This evidence concerns the gene TMPRSS2 and Familial prostate cancer.